SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-027006
Filing Date
2022-12-23
Accepted
2022-12-23 16:10:31
Documents
20
Period of Report
2022-12-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-20221220.htm   iXBRL 8-K 66577
2 EX-1.1 tern-ex1_1.htm EX-1.1 434980
3 EX-5.1 tern-ex5_1.htm EX-5.1 23664
4 EX-99.1 tern-ex99_1.htm EX-99.1 16166
5 GRAPHIC img52906712_0.jpg GRAPHIC 5450
6 GRAPHIC img60210087_0.jpg GRAPHIC 6612
7 GRAPHIC img60210087_1.jpg GRAPHIC 20696
8 GRAPHIC img60210087_2.jpg GRAPHIC 19904
9 GRAPHIC img60210087_3.jpg GRAPHIC 49249
  Complete submission text file 0000950170-22-027006.txt   877865

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20221220.xsd EX-101.SCH 2478
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20221220_pre.xml EX-101.PRE 10683
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20221220_lab.xml EX-101.LAB 14572
14 EXTRACTED XBRL INSTANCE DOCUMENT tern-20221220_htm.xml XML 5117
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 221485476
SIC: 2834 Pharmaceutical Preparations